Aging and Estrogen on Cortical Function
The Effect of Low Dose Estrogen on Cortical Function as a Function of Age in Postmenopausal Women.
Sponsor: Massachusetts General Hospital
This PHASE1/PHASE2 trial investigates Cognitive Changes and Memory Loss and is currently completed. Massachusetts General Hospital leads this study, which shows 7 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Sep 2018 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed · Phase: PHASE4 → PHASE1_PHASE2
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting PHASE4
▶ Show 2 earlier versions
-
Apr 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE4
Status: Unknown Status → Active Not Recruiting · Phase: NA → PHASE4
-
Jan 2017 — Apr 2017 [monthly]
Unknown Status NA
First recorded
Nov 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
- National Institute on Aging (NIA)
For direct contact, visit the study record on ClinicalTrials.gov .